[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:neuroendocrine-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":110,"states":119},"Neuroendocrine Carcinoma",16,14,[8,16,23,30,37,42,48,54,60,66,72,78,84,90,96,103],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06885281","A Study of ZL-1310 in Participants With Selected Solid Tumors",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:15:53.461103Z","2026-07-19T19:36:05.058172Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06889493","SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)",[20],"Phase 1","2026-08-26T02:18:17.950264Z","2026-05-05T02:43:28.317139Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT07544654","A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy",[27],"Phase 3","2026-08-26T02:16:16.169331Z","2026-05-05T02:43:26.717266Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":35,"content_modified":36},"NCT06202066","Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas",[34],"Phase 2","2026-08-03T02:57:18.103669Z","2026-05-05T02:43:29.222571Z",{"nct_id":38,"title":39,"phases":40,"status":13,"updated_at":28,"content_modified":41},"NCT07278479","Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors",[12],"2026-05-05T02:43:28.190947Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT07129252","A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors",[12],"2026-08-26T02:15:56.561131Z","2026-05-05T02:43:27.489197Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT05652686","A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)",[12],"2026-08-26T02:16:14.341106Z","2026-07-19T19:36:05.121911Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07174583","A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer",[12],"2026-08-26T02:16:21.385056Z","2026-07-19T19:36:05.070754Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT04429087","A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3",[20],"2026-08-03T00:53:42.755927Z","2026-07-05T05:32:16.773103Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT06943521","A Study of MT-4561 in Patients With Various Advanced Solid Tumors",[12],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:28.477669Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06161532","Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder\u002FUrinary Tract Cancer, Renal Medullary Carcinoma and Penile C...",[34],"2026-08-26T02:16:46.147215Z","2026-05-05T02:43:28.172497Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT06788938","Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms",[34],"2026-08-26T02:17:55.355429Z","2026-05-05T02:43:27.447902Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT05969860","At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer",[34],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:26.978986Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT05841563","Clinical Trial of PM54 in Advanced Solid Tumors Patients.",[20],"2026-08-26T02:15:18.897219Z","2026-05-05T02:43:26.706220Z",{"nct_id":97,"title":98,"phases":99,"status":100,"updated_at":101,"content_modified":102},"NCT02270567","RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:05.997056Z","2026-06-16T05:54:07.950523Z",{"nct_id":104,"title":105,"phases":106,"status":107,"updated_at":108,"content_modified":109},"NCT06132113","DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T02:14:57.006298Z","2026-05-05T02:43:28.545812Z",[111,115],{"biomarker":112,"count":113,"slug":114},"MKI67 Gene",4,"mki67-gene",{"biomarker":116,"count":117,"slug":118},"DLL3 Gene",3,"dll3-gene",[120,124,128,131,135,138,141,144,147,150,153,156,159,162,165,168],{"state":121,"count":122,"slug":123},"Texas",7,"texas",{"state":125,"count":126,"slug":127},"California",6,"california",{"state":129,"count":126,"slug":130},"Pennsylvania","pennsylvania",{"state":132,"count":133,"slug":134},"Florida",5,"florida",{"state":136,"count":133,"slug":137},"Georgia","georgia",{"state":139,"count":133,"slug":140},"Maryland","maryland",{"state":142,"count":133,"slug":143},"New York","new-york",{"state":145,"count":113,"slug":146},"Michigan","michigan",{"state":148,"count":113,"slug":149},"Virginia","virginia",{"state":151,"count":117,"slug":152},"Colorado","colorado",{"state":154,"count":117,"slug":155},"Connecticut","connecticut",{"state":157,"count":117,"slug":158},"Illinois","illinois",{"state":160,"count":117,"slug":161},"Missouri","missouri",{"state":163,"count":117,"slug":164},"Ohio","ohio",{"state":166,"count":117,"slug":167},"Tennessee","tennessee",{"state":169,"count":117,"slug":170},"Washington","washington"]